bf/NASDAQ:ADMA_icon.jpeg

NASDAQ:ADMA

ADMA Biologics, Inc.

  • Stock

USD

Last Close

14.03

06/11 22:02

Market Cap

2.78B

Beta: 0.91

Volume Today

2.73M

Avg: 2.30M

PE Ratio

−27.46

PFCF: −49.81

    Description

    ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ...Show More

    Earnings

    Earnings per Share (Estimate*)

    -0.3-0.2-0.10.12019-08-082020-12-302021-12-302023-11-082024-11-06

    Revenue (Estimate*)

    20M40M60M80M100M120M2019-08-082020-12-302021-12-302023-11-082024-11-06

    *Estimate based on analyst consensus